Metallus SEC Filings

Meta Platforms (META) Chief Operating Officer Javier Olivan filed a Form 4 disclosing a Rule 10b5-1 sale on 07/21/2025. He sold 517 Class A shares at $706.41 each, generating roughly $365 k in gross proceeds. The transaction was pre-scheduled, limiting its signaling value.

Following the sale, Olivan directly owns 6,302 shares. Indirect holdings remain substantial: 8,622 shares in Olivan D LLC, 2,999 in Olivan Reinhold D LLC, 8,622 in Reinhold D LLC, and 90,493 in the Olivan Reinhold Family Revocable Trust—bringing total reported beneficial ownership to 117,038 shares.

No derivative transactions were reported, and there is no indication of material change in overall ownership or company fundamentals. Given the modest size versus total holdings and the use of a 10b5-1 plan, the filing is generally viewed as neutral for investors.

Meta Platforms (META) Chief Operating Officer Javier Olivan filed a Form 4 disclosing a Rule 10b5-1 sale on 07/21/2025. He sold 517 Class A shares at $706.41 each, generating roughly $365 k in gross proceeds. The transaction was pre-scheduled, limiting its signaling value.

Following the sale, Olivan directly owns 6,302 shares. Indirect holdings remain substantial: 8,622 shares in Olivan D LLC, 2,999 in Olivan Reinhold D LLC, 8,622 in Reinhold D LLC, and 90,493 in the Olivan Reinhold Family Revocable Trust—bringing total reported beneficial ownership to 117,038 shares.

No derivative transactions were reported, and there is no indication of material change in overall ownership or company fundamentals. Given the modest size versus total holdings and the use of a 10b5-1 plan, the filing is generally viewed as neutral for investors.

Safe & Green Holdings Corp. (Nasdaq: SGBX) has called a virtual special meeting for 25 Aug 2025 to seek shareholder approval on three key items:

• Proposal 1 – Reverse Stock Split: Board discretion to combine shares at any ratio between 1-for-10 and 1-for-100 within one year. Main objective is to lift the bid price above Nasdaq’s US$1.00 minimum after two deficiency notices and a Hearing Panel deadline of 28 Aug 2025.
• Proposal 2 – Issuance of Series B Preferred Conversion Shares: Approval under Nasdaq Rule 5635(d) to issue all common shares underlying 60,000 newly issued Series B convertible preferred shares obtained via a warrant-for-preferred exchange completed 17 Jul 2025. Conversion price is US$0.392 per share but is capped at 19.99 % of outstanding common stock until shareholder consent is obtained.
• Proposal 3 – Adjournment: Authority to adjourn the meeting to solicit additional proxies if needed.

The record date is 11 Jul 2025 with 10,120,651 common shares outstanding. A quorum requires one-third of voting power. The board recommends voting FOR all proposals. Failure to effect the reverse split and regain compliance could lead to delisting; conversely, approval would give management flexibility to meet Nasdaq conditions but may increase dilution and market volatility for existing investors.

Atlassian (TEAM) Form 4: CEO, co-founder and 10% owner Michael Cannon-Brookes sold a total of 7,765 Class A shares on 22 Jul 2025 under a pre-arranged Rule 10b5-1 plan adopted 20 Feb 2025.

The stock was disposed of in seven separate trades at weighted-average prices between $195.965 and $202.35, generating roughly $1.55 million in gross proceeds. Following the sales, the insider—through CBC Co Pty Ltd as trustee of the Cannon-Brookes Head Trust—continues to hold 375,585 Class A shares, maintaining more than 98% of his prior indirect position and his 10% beneficial-owner status.

No derivative activity or purchases were reported. Given the modest 2% reduction in holdings and the existence of a 10b5-1 plan, the transactions appear routine and are unlikely to materially alter insider alignment, though any CEO liquidation can create short-term sentiment pressure.

Form 144 filed for Metallus Inc. (MTUS) discloses that shareholder Kristine Syrvalin intends to sell up to 7,500 common shares through Merrill Lynch on or about 23 Jul 2025 on the NYSE. The shares have an estimated aggregate market value of $135,000, representing roughly 0.018 % of the 42.0 million shares outstanding.

The securities were acquired via employee equity awards: 4,741 RSUs vested 1 Mar 2024 and two PSU tranches (910 + 1,849) vested 2 Mar 2023. During the past three months Syrvalin has already sold 7,500 shares (2 Jul 2025) for $120,000. No material adverse information is asserted, and no 10b5-1 plan is referenced.

The proposed transaction is modest in size and does not materially alter MTUS’s share count, but it signals continued insider monetization of vested equity awards.

Metallus Inc. (symbol: MTUS) has filed a Form 144 indicating the proposed sale of 7,500 common shares through Merrill Lynch, Atlanta, on or about July 2, 2025. The filing assigns an aggregate market value of $120,000 to the planned transaction. The shares were originally acquired on March 1, 2024 via a restricted stock unit (RSU) vesting-related compensatory award from Metallus. No other sales by the same insider have occurred in the past three months, and no material, non-public adverse information is asserted in the certification section. With 42,023,268 total shares outstanding, the planned disposition represents roughly 0.018% of the company’s equity, making it immaterial from a dilution perspective but potentially relevant for investors tracking insider sentiment.

On 30 June 2025, SANUWAVE Health, Inc. (ticker: SNWV) granted Director Jeffrey Blizard a fully-vested stock option covering 1,574 shares of common stock, as disclosed in a Form 4 filed on 2 July 2025. The option carries an exercise price of $32.86 and an expiration date of 30 June 2030. The transaction was coded “A,” indicating an issuer-awarded grant rather than an open-market purchase. No non-derivative transactions or additional derivative movements were reported.

Following this grant, Mr. Blizard directly owns 1,574 derivative securities and reported no other holdings in SNWV common stock. Because the options were already fully vested at issuance, they are immediately exercisable, potentially aligning the director’s incentives with shareholder value creation. However, the filing does not specify any accompanying cash outlay or further equity activity.

Badger Meter, Inc. (BMI) – Form 4 filing: Director Todd A. Adams reported the automatic issuance of 65.32 phantom stock units on 07/01/2025. These units, equal in value to common shares, were credited to his Director Deferred Compensation Plan as payment of the Q3-2025 cash retainer of $16,000, valued at the 06/30/2025 closing price of $244.95 per share. Following the transaction, Adams now holds 15,694.767 phantom units, recorded as direct ownership. Phantom stock is settled in cash once the director leaves the board, so no immediate share issuance or market purchase occurs. The filing reflects routine board compensation rather than an open-market insider buy or sell and is unlikely to materially affect BMI’s share float or signaling dynamics.

Badger Meter, Inc. (BMI) – Form 4 filing: Director Todd A. Adams reported the automatic issuance of 65.32 phantom stock units on 07/01/2025. These units, equal in value to common shares, were credited to his Director Deferred Compensation Plan as payment of the Q3-2025 cash retainer of $16,000, valued at the 06/30/2025 closing price of $244.95 per share. Following the transaction, Adams now holds 15,694.767 phantom units, recorded as direct ownership. Phantom stock is settled in cash once the director leaves the board, so no immediate share issuance or market purchase occurs. The filing reflects routine board compensation rather than an open-market insider buy or sell and is unlikely to materially affect BMI’s share float or signaling dynamics.